The rivalry between Pfizer and MSD in pneumococcal vaccines has dialled up a notch with the FDA approval of MSD’s new shot Capvaxive, the first to be aimed specifically at adults. The 21-valent ...

MSD has decided to abandon the development of its anti-TIGIT antibody vibostolimab and anti-LAG-3 antibody favezelimab, blowing a hole in its immuno-oncology pipeline. The demise of the two ...

In response to the surging global demand for pre-owned goods, international technology firm Ronati has launched Studio, a ...

By integrating Medit SmartX with Imagoworks' AOX, dental professionals can streamline the edentulous prosthetic workflow, ...

SEOUL, South Korea and NEWPORT BEACH, Calif., March 18, 2025 /PRNewswire/ -- Medit ( a global leader in digital dentistry, ...